Austin [Texas]: An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of mostly low-grade side effects, researchers reported on Wednesday. The report from a first-in-human trial of daraxonrasib is the first peer-reviewed paper to show safety data for what […]